Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Epidemiology: Psoriasis | Mar 2011 | £3,605 | 100% |
| Psoriasis Market Forecast | Dec 2010 | £9,615 | 99% |
| Psoriasis Therapy Area Pipeline Report | Mar 2011 | £945 | 99% |
| U.S. Market for Psoriasis Cream and Medication 2009 | Mar 2009 | £4,740 | 97% |
| Psoriasis and Psoriatic Arthritis A Strategic Analysis of the Market in the United States |
Sep 2006 | £2,215 | 97% |
| Psoriasis Drugs | Apr 2010 | £2,500 | 97% |
| Psoriasis Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Oct 2011 | £2,215 | 97% |
| Psoriasis - Pipeline Review H2 2011 |
Sep 2011 | £315 | 96% |
| Psoriasis Global Clinical Trials Review Q1, 2011 |
Mar 2011 | £630 | 96% |
| Chronic Plaque Psoriasis - Pipeline Review H2 2011 |
Aug 2011 | £315 | 96% |
| Chronic Plaque Psoriasis Global Clinical Trials Review H2, 2011 |
Oct 2011 | £630 | 96% |
| Commercial and Pipeline Insight: Psoriasis Established brands challenged by new therapies |
Dec 2010 | £9,615 | 95% |
| Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete Healthcare |
Mar 2009 | £8,365 | 94% |
| 2008 U.S. Inflammatory Disease Drug Delivery Patient Perspective |
Nov 2010 | £6,325 | 93% |
| Dermatological Drugs World Market 2011-2026 |
Nov 2010 | £1,499 | 91% |
| The World Dermatological Market Outlook 2010-2024 |
Nov 2009 | £1,499 | 91% |
| Autoimmune Treatment 2009 - 2014 |
Sep 2009 | £2,940 | 90% |
| Dermatology Therapeutics Market to 2017 Alopecia Market Is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline |
Jan 2012 | £2,215 | 90% |
| Clinical Trial Recruitment in Autoimmune Disorders Average Patient Recruitment per Trial Has Continued to Decline over The past Decade |
Sep 2011 | £2,215 | 89% |
| The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 Increasing Prescription Rate to Drive Revenues |
Mar 2010 | £2,215 | 89% |
| Spinal Surgery | Oct 2011 | £2,845 | 88% |
| Market for Prescription Dermatological Drugs, 7th Edition, The | Apr 2010 | £2,465 | 88% |
| Biotech in Autoimmune and Inflammatory Disease 2006 2nd Edition |
May 2006 | £1,895 | 88% |
| Anti-Inflammatory Therapeutics Market to 2017 Respiratory Diseases and Arthritis Continue to Dominate |
Oct 2011 | £2,215 | 87% |
| The Future of Autoimmune Diseases Therapeutics Market Forecasts to 2015 |
Dec 2009 | £2,215 | 86% |
| Therapeutics for Inflammatory Diseases: Current Challenges and Future Market | Jan 2006 | £2,760 | 86% |
| Inflammatory Directions Strategies for Six Diseases with Unmet Needs |
Apr 2008 | £710 | 85% |
| Stakeholder Opinion: Atopic Dermatitis A high level of unmet need creates market opportunities |
Mar 2007 | £2,400 | 84% |
| Dermatological Therapeutics Global Markets |
Jan 2009 | £3,065 | 82% |
| 2008 U.S. Inflammatory Diseases Drug Delivery Physician Perspective |
Nov 2010 | £6,325 | 81% |
